Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-23 00:05 CEST (UTC+2h)

bioequivalence criteria for NTID [Regulatives / Guidelines]

posted by Biostats - India, 2018-03-29 12:39  - Posting: # 18613
Views: 1,456

Dear All,

As per Draft Guidance on Warfarin Sodium bioequivalence criteria for NTID as
  1. Every study should pass the scaled average bioequivalence limits and
  2. Also regular unscaled bioequivalence limits of 80.00-125.00%.
  3. the upper limit of the 90% equal-tails confidence interval for σwT/σwR is less than or equal to 2.5
My understanding for 1 and 2 criteria as below,
  1. The 95% upper confidence bound for (YTYR)2θs2wR must be ≤ 0 and the point estimate of the Test/Reference geometric mean ratio must fall within 80.00 – 125.00%. (scaled average bioequivalence limits)
  2. 90% confidence interval should lies within 80–125% (unscaled bioequivalence limits)
Is this correct? Please guide me to understand the bioequivalence criteria of NTI drugs.

Thanks in advanced.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,190 registered users;
online 19 (0 registered, 19 guests [including 17 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed